000 | 01907 a2200553 4500 | ||
---|---|---|---|
005 | 20250516064527.0 | ||
264 | 0 | _c20120427 | |
008 | 201204s 0 0 eng d | ||
022 | _a1872-7573 | ||
024 | 7 |
_a10.1016/j.jep.2011.11.002 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChen, Jinglou | |
245 | 0 | 0 |
_aRenoprotective potential of Macrothelypteris torresiana via ameliorating oxidative stress and proinflammatory cytokines. _h[electronic resource] |
260 |
_bJournal of ethnopharmacology _cJan 2012 |
||
300 |
_a207-13 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBlood Glucose _xanalysis |
650 | 0 | 4 | _aBlood Urea Nitrogen |
650 | 0 | 4 |
_aCreatinine _xblood |
650 | 0 | 4 | _aDiet, High-Fat |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aDrugs, Chinese Herbal _xpharmacology |
650 | 0 | 4 | _aFerns |
650 | 0 | 4 |
_aHyperlipidemias _xdrug therapy |
650 | 0 | 4 |
_aKidney _xdrug effects |
650 | 0 | 4 |
_aLipid Peroxidation _xdrug effects |
650 | 0 | 4 |
_aLipids _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aNephrotic Syndrome _xchemically induced |
650 | 0 | 4 |
_aNitric Oxide _xblood |
650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xblood |
650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
650 | 0 | 4 | _aPhytotherapy |
650 | 0 | 4 |
_aPolyphenols _xpharmacology |
650 | 0 | 4 | _aPotassium Dichromate |
650 | 0 | 4 |
_aProtective Agents _xpharmacology |
650 | 0 | 4 | _aPuromycin Aminonucleoside |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xblood |
700 | 1 | _aLei, Yongfang | |
700 | 1 | _aWu, Guanghua | |
700 | 1 | _aZhang, Yonghui | |
700 | 1 | _aFu, Wei | |
700 | 1 | _aXiong, Chaomei | |
700 | 1 | _aRuan, Jinlan | |
773 | 0 |
_tJournal of ethnopharmacology _gvol. 139 _gno. 1 _gp. 207-13 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jep.2011.11.002 _zAvailable from publisher's website |
999 |
_c21328355 _d21328355 |